Précisez une action ou une cryptomonnaie dans la barre de recherche pour obtenir un récapitulatif
Aurobindo Pharma Limited
AUROPHARMAAurobindo Pharma Limited, a biopharmaceutical company, engages in the manufacture of generic formulations and active pharmaceutical ingredients in India, the United States of America, Europe, Puerto Rico, and internationally. The company offers formulation in form of oral solids, liquids, injectables, and vaccines, as well as over-the-counter drugs; and active pharmaceutical ingredients (APIs), biosimilars, biocatalysts, peptides, and hormones targeting key therapeutic areas, including central nervous system, cardiovascular, respiratory, antibiotics, anti-retroviral, anti-diabetics, gastroenterology, oncology, and dermatology. It also provides antiretroviral drugs for the people and children living with HIV; and provides project-based chemistry contract services that cover the clinical stage through to manufacturing and management of the entire drug lifecycle in the API space for sterile and non-sterile penicillin's, cephalosporins, penems, and non-beta lactams. The company was incorporated in 1986 and is headquartered in Hyderabad, India. Address: Galaxy, Plot No. 1, Hyderabad, India, 500032
Analytics
Objectif de Cours de WallStreet
79 738.14 INRRatio C/B
26.0687Rendement du dividende
0.29 %Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Année actuelle
L'année dernière
Trimestre en cours
Le dernier trimestre
Chiffres clés AUROPHARMA
Analyse des dividendes AUROPHARMA
Croissance des dividendes sur 5 ans
167 %Croissance continue
–Ratio de distribution Moyenne sur 5 ans
10 %Historique des dividendes AUROPHARMA
Valorisation des titres AUROPHARMA
financières AUROPHARMA
Résultats | 2019 | Dynamique |